Systemic Lupus Erythematosus
NCT05984316 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2023-10-18
Summary
Systemic lupus erythematosus (SLE) is a chronic autoimmune and inflammatory disease. The pathogenesis of SLE results from interactions between genes, hormones, and the environment; however, the exact etiology is unknown. SLE can affect many organs and systems, including the musculoskeletal, hematological, renal, neuropsychiatric, cardiovascular and pulmonary systems, and skin. Non-specific general complaints such as malaise, fatigue, arthralgia, anxiety, depression, fever, and weight loss are evident at the onset of the disease and during the activation periods. Patients experience hopelessness due to the complexity of the symptoms and the chronic and progressive nature of the disease, and they experience deterioration in their quality of life due to the interaction of anxiety and depression findings with other symptoms. SLE is a difficult disease to manage because of the different organ and system involvement processes.
In addition, these symptoms of the disease and the nature of chronic pain, including central sensitization, cause it to accompany a process that is affected by the mood of the person. Some patients present to a rheumatologist with mild symptoms, while others may present with severe, life-threatening symptoms. The onset of the disease before the age of 18 is defined as childhood onset (juvenile). Childhood-onset SLE accounts for approximately 1/5 of SLE patients. It is known that the main mechanism in the formation of the disease is the production of more than one autoantibody.
Although childhood SLE (jSLE) appears to be basically the same disease with similar etiology, pathogenesis, and laboratory findings as in adults, there are differences in the frequency and severity of clinical manifestations. In this respect, the clearest finding is that children with SLE have greater disease severity and earlier disease-related organ damage than adults with SLE. Studies on the disease show that patients with jSLE have not only physical but also cognitive effects.
The aim of our study is to examine the effects of exercises applied with a dual-task approach on patients' physical and cognitive status in jSLE cases.
Conditions
- System; Lupus Erythematosus
- Cognition Disorder
- Autoimmune
Interventions
- OTHER
-
Exercise
Dual task exercises are defined as the appropriate direction of attention during two activities performed at the same time. Dual task performance is required during many activities in daily life. Multitasking is complicated to understand because it is divided into social, physical, and psychological branches. The simultaneous occurrence of movement and cognitive processes is seen as a part of social participation. Considering that one task affects the other, dual task is defined as the simultaneous performance of two tasks that can be performed independently, can be evaluated separately, and have different purposes. Each task must be incompatible and measurable, achievable alone or in different combinations. The increased need for information processing alone does not constitute dual-tasking.
Sponsors & Collaborators
-
Biruni University
lead OTHER
Principal Investigators
-
eylul Pinar kısa · Istanbul University - Cerrahpasa
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-02
- Primary Completion
- 2023-12-02
- Completion
- 2023-12-05
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Motivating Individuals With Lupus to Exercise
NCT05287581 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus
NCT01904812 ·Status: COMPLETED ·Phase: NA
-
Exercise and Systemic Lupus Erythematosus
NCT01515163 ·Status: UNKNOWN ·Phase: NA
-
Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus Patients
NCT05478018 ·Status: COMPLETED ·Phase: NA
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Fatigue in Systemic Lupus Erythematosus
NCT06652256 ·Status: COMPLETED
-
Observational Study Investigating Demographic and Clinical Characteristics of SLE Patients in Egypt
NCT07144514 ·Status: NOT_YET_RECRUITING
-
Effects of Telehealth Initiative on Lupus Patients
NCT05329831 ·Status: COMPLETED ·Phase: NA
-
Water-based Liuzijue Exercise on Childhood-onset Systemic Lupus Erythematosus
NCT07024082 ·Status: COMPLETED ·Phase: NA
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
The Role of Some Hematological Parameters in Juvenile Systemic Lupue Erythematosus
NCT06227559 ·Status: NOT_YET_RECRUITING
-
the Association Between Metabolic Syndrome and Its Components With Lupus Nephritis in Systemic Lupus Erythematosus Patients
NCT05964751 ·Status: UNKNOWN
-
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
NCT04276701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus
NCT00042523 ·Status: COMPLETED
-
Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients
NCT05971498 ·Status: UNKNOWN
-
Activity and Nutrition Trial in Lupus to Energize and Renew
NCT02281513 ·Status: COMPLETED ·Phase: NA
-
Improving the Assessment of SLE Disease Activity
NCT03144063 ·Status: COMPLETED
-
Neuropsycatric Disorders Among Children With Systemic Lupus Erythematosus in Sohag University Hospital
NCT06449794 ·Status: RECRUITING
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED
-
Clinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in Russia
NCT06759519 ·Status: COMPLETED
-
Laser Therapy for Patients With Systemic Lupus Erythematosus
NCT04453215 ·Status: COMPLETED ·Phase: NA
-
Healthy Lifestyle Intervention in Patients with Systemic Lupus Erythematosus: the Living Well with Lupus Study
NCT04431167 ·Status: COMPLETED ·Phase: NA
-
Interleukin23 in Systemic Lupus
NCT06713187 ·Status: RECRUITING ·Phase: NA
-
Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus
NCT06166199 ·Status: RECRUITING ·Phase: NA
-
Fatigue, Depression, and Cortical Excitability in Systemic Lupus
NCT03165682 ·Status: UNKNOWN